Fosphenytoin Sodium Injection, Solution
Product Images NDC 0143-9788

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosphenytoin Sodium (NDC 0143-9788). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by West-ward Pharmaceuticals Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fosphenytoin Sodium Injection 1)

Structure (Fosphenytoin Sodium Injection 1)
Chemical structure of Fosphenytoin Sodium showing a complex organic molecule with diphenyl groups, a phosphonate group, and associated sodium ions, consistent with the active ingredient's molecular composition.*
FDA Label Image

Graph (Fosphenytoin Sodium Injection 2)

Graph (Fosphenytoin Sodium Injection 2)
A pharmacokinetic graph showing plasma unbound phenytoin concentration (µg/mL) over time up to 2 hours after start of infusion, with multiple data series indicated by different symbols. An inset graph extends the time course to 96 hours, depicting the decline of plasma unbound phenytoin concentration over the extended period.*
FDA Label Image

2 mL Container (Fosphenytoin Sodium Injection 3)

2 mL Container (Fosphenytoin Sodium Injection 3)
Fosphenytoin Sodium Injection, USP label for 100 mg PE/2 mL (50 mg PE/mL) solution for intramuscular or intravenous use, single dose vial, distributed by West-Ward Pharmaceuticals Corp. The label includes storage instructions, dosage form, route, and barcode.*
FDA Label Image

10 mL Vial Container (Fosphenytoin Sodium Injection 4)

10 mL Vial Container (Fosphenytoin Sodium Injection 4)
Fosphenytoin Sodium Injection, USP 500 mg PE/10 mL (50 mg PE/mL) label for a 10 mL single-dose vial. The label states dosage form as injection solution for intramuscular or intravenous use and includes storage instructions to refrigerate at 2° to 8°C. Manufactured by Hikma Farmacêutica (Portugal) and distributed by West-Ward Pharmaceuticals Corp.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.